Shanghai New World Co., Ltd

600628

CNE0000006X1

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
6.38 ^CNY	-0.16%		+1.43%	-8.99%

Apr. 29	Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 12	Shanghai New World Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024

April 29, 2024 at 04:56 am EDT

Shanghai New World Co., Ltd reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 275.82 million compared to CNY 264.6 million a year ago. Revenue was CNY 275.82 million compared to CNY 264.6 million a year ago.

Net income was CNY 25.85 million compared to CNY 23.91 million a year ago. Basic earnings per share from continuing operations was CNY 0.04 compared to CNY 0.04 a year ago. Diluted earnings per share from continuing operations was CNY 0.04 compared to CNY 0.04 a year ago.

Latest news about Shanghai New World Co., Ltd

Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 12	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-12	CI
Shanghai New World Co., Ltd completed the acquisition of 6.1245% of stake in Zhejiang Guojun Co., Ltd. from Shen Guojun and Shen Junyan	23-03-06	CI
Shanghai New World Co., Ltd agreed to acquire 6.1245% of stake in Zhejiang Guojun Co., Ltd. from Shen Guojun and Shen Junyan for approximately CNY 490 million.	23-02-17	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-30	CI
Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-26	CI
Shanghai Cai Tongde Pharmaceutical Co., Ltd. announced that it has received CNY 20 million in funding from Shanghai New World Co., Ltd	21-08-17	CI
Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-29	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-14	CI
Shanghai Cai Tongde Pharmaceutical Co., Ltd. announced that it expects to receive CNY 20 million in funding from Shanghai New World Co., Ltd	21-01-17	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-29	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-27	CI
Shanghai New World Co., Ltd Announces Cash Dividend on A Share for the Year 2019, Payable on August 21, 2020	20-08-15	CI
Shanghai New World Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-29	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-16	CI
Shanghai New World Co., Ltd Announces Earnings Guidance for 2019	20-01-20	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-30	CI
Shanghai New World Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-27	CI

Chart Shanghai New World Co., Ltd

Duration

Period

More charts

Company Profile

Shanghai New World Co Ltd is a China-based company mainly engaged in department store retail enterprises integrating modern department stores, tourism, leisure and entertainment comprehensive consumption. The Company operates its businesses through four segments. The Commercial segment is principally engaged in department store retail. The Pharmaceutical Industry segment is mainly engaged in the sales of various types of chinese medicinal materials, chinese patent medicines, western medicines, ginseng and antler supplements, nutritional health products and medical equipment. The Hotel Services segment is principally engaged in the operation of Radisson brand hotels managed by Radisson Hotel Group. The Company is also engaged in other businesses segment. The Company mainly operates its businesses in the domestic market.

Sector

Pharmaceuticals

Calendar

2024-08-27 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SHANGHAI NEW WORLD CO., LTD	-8.99%	571M
ELI LILLY AND COMPANY	+37.88%	705B
NOVO NORDISK A/S	+32.82%	583B
JOHNSON & JOHNSON	-3.75%	364B
MERCK & CO., INC.	+19.80%	332B
ABBVIE INC.	+5.01%	291B
ASTRAZENECA PLC	+16.64%	238B
ROCHE HOLDING AG	-4.13%	210B
NOVARTIS AG	+10.63%	209B
AMGEN INC.	+8.95%	169B

Other Pharmaceuticals